<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-25678" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Neonatal Sepsis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Singh</surname>
            <given-names>Meenakshi</given-names>
          </name>
          <aff>Penn State Milton S. Hershey Med. Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Alsaleem</surname>
            <given-names>Mahdi</given-names>
          </name>
          <aff>University of Kansas /Children's Mercy Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gray</surname>
            <given-names>Cory P.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Meenakshi Singh declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Mahdi Alsaleem declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Cory Gray declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>29</day>
          <month>9</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-25678.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Neonatal sepsis refers to an infection involving the bloodstream in infants under 28 days old. It continues to remain a leading cause of morbidity and mortality among infants, especially in middle and lower-income countries. It is divided into early-onset sepsis (EOS) or late-onset sepsis (LOS) based on the age of presentation after birth, with different experts using 72 hours or 7 days as the cutoff. This activity describes the treatment and evaluation of neonatal sepsis and explains the role of the interprofessional team in managing patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Assess the etiology of early and late-onset neonatal sepsis.</p></list-item><list-item><p>Evaluate&#x000a0;various clinical and laboratory findings associated with neonatal sepsis</p></list-item><list-item><p>Differentiate&#x000a0;the various treatment and management options available for neonatal sepsis.</p></list-item><list-item><p>Communicate&#x000a0;the importance of improving care coordination amongst interprofessional team members to improve outcomes for neonates affected by sepsis.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25678&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25678">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-25678.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Neonatal sepsis is an infection involving the bloodstream in infants under 28 days old. It remains a leading cause of morbidity and mortality among neonates, especially in middle and lower-income countries&#x000a0;<xref ref-type="bibr" rid="article-25678.r1">[1]</xref>. Neonatal sepsis is divided into&#x000a0;2 groups based on the time of presentation after birth: early-onset sepsis (EOS) and late-onset sepsis (LOS). EOS refers to sepsis in neonates at or before 72 hours of life (some experts use&#x000a0;7 days), and LOS is defined as sepsis occurring at or after 72 hours of life&#x000a0;<xref ref-type="bibr" rid="article-25678.r2">[2]</xref>.</p>
      </sec>
      <sec id="article-25678.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>EOS is generally caused by the transmission of pathogens from the female genitourinary system to the newborn or the fetus. These pathogens can ascend the vagina, the cervix, and the uterus and can also infect the amniotic fluid. Neonates can also become infected in utero or during delivery as they pass through the vaginal canal. Typical bacterial pathogens for EOS include group B streptococcus (GBS), Escherichia coli, coagulase-negative Staphylococcus, Haemophilus influenza, and Listeria monocytogenes. Maternal factors that increase the risk of neonatal sepsis include chorioamnionitis, GBS colonization, delivery before 37 weeks, and prolonged rupture of membranes greater than 18 hours&#x000a0;<xref ref-type="bibr" rid="article-25678.r3">[3]</xref>.</p>
        <p>LOS usually occurs via transmitting pathogens from the surrounding environment after delivery, such as contact from healthcare workers or caregivers. A percentage of LOS may also be caused by a late manifestation of vertically transmitted infection. Infants requiring intravascular catheter insertion or other invasive procedures that disrupt the mucosa are at increased risk for developing LOS.&#x000a0;Preterm neonates are at higher risk for sepsis/infection than term neonates. The increased susceptibility for infections seen in preterm neonates is mainly due to :&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Deficient immune system, mainly due to decreased IgG antibodies and incompetent opsonization and complement activation</p>
          </list-item>
          <list-item>
            <p>Comprised innate immune system, caused primarily by the immature epithelial barrier</p>
          </list-item>
          <list-item>
            <p>The increased need for invasive devices (vascular access, endotracheal tube, feeding tubes, and urinary tract catheters) due to associated severe illnesses</p>
          </list-item>
        </list>
        <p>Coagulase-negative staphylococcal species, especially Staphylococcus epidermis, are the leading cause, responsible for over 50% of LOS cases in industrialized countries. However, many other bacterial and viral pathogens can be associated with LOS&#x000a0;<xref ref-type="bibr" rid="article-25678.r3">[3]</xref>.&#x000a0;</p>
      </sec>
      <sec id="article-25678.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The epidemiology of neonatal sepsis has been changing with time&#x000a0;<xref ref-type="bibr" rid="article-25678.r4">[4]</xref>. The incidence of EOS has decreased since the 1990s due to the introduction of universal screening of GBS in pregnant women and intrapartum antibiotic prophylaxis<xref ref-type="bibr" rid="article-25678.r5">[5]</xref>. However, rates of LOS have remained relatively the same. Escherichia coli now accounts for more cases of EOS&#x000a0;&#x000a0;<xref ref-type="bibr" rid="article-25678.r6">[6]</xref>. The incidence of EOS with positive blood cultures in the United States is estimated to be 0.77 to 1 per 1,000 live births&#x000a0;<xref ref-type="bibr" rid="article-25678.r7">[7]</xref><xref ref-type="bibr" rid="article-25678.r8">[8]</xref>. Due to the nonspecific neonatal presentation for sepsis and the high risk of mortality and morbidity without treatment, many asymptomatic neonates undergo a sepsis workup if risk factors are present and/or clinically indicated. Although approximately 7% to 13% of all neonates are treated for sepsis, only 3% to 8% have positive cultures&#x000a0;<xref ref-type="bibr" rid="article-25678.r3">[3]</xref>. Maternal administration of antibiotics and the low blood volume obtained for blood culture could explain the low rate of positive blood cultures. The incidence of sepsis is significantly higher in premature infants, as well as those with very low birth weight (&#x0003c;1000 grams). African American infants have an increased risk of GBS and LOS, likely secondary to the higher rate of GBS carrier rates in African American females. Males have a higher risk of sepsis and meningitis, especially with gram-negative enteric bacilli&#x000a0;<xref ref-type="bibr" rid="article-25678.r3">[3]</xref>.&#x000a0;</p>
      </sec>
      <sec id="article-25678.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The immature immune system is the major contributing factor to increased neonatal susceptibility to sepsis. The immature function of polymorphonuclear neutrophils, macrophages, and T lymphocytes makes these cells incapable of carrying out a complete inflammatory response in neonates. Furthermore, neonates have limited immunoglobulins at birth and cannot generate a quantitative and/or qualitative adequate mounting response against infectious agents. The insufficient time that premature has in the uterus decreases the transfer of immune globulins to the fetus. This deficiency in immunoglobulins puts premature infants at much higher risk for sepsis when compared to term infants&#x000a0;<xref ref-type="bibr" rid="article-25678.r9">[9]</xref>.&#x000a0;</p>
      </sec>
      <sec id="article-25678.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Signs and symptoms of neonatal sepsis can range from nonspecific or vague symptoms to hemodynamic collapse.&#x000a0;Early symptoms may include irritability, lethargy, or poor feeding. Others may quickly develop&#x000a0;respiratory distress, fever, hypothermia, or hypotension with poor perfusion and shock. Sometimes, the diagnosis may only be suspected based on laboratory findings, which may reveal&#x000a0;hyperglycemia or hypoglycemia, acidosis, or hyperbilirubinemia.&#x000a0;A high index of suspicion is, therefore, necessary for timely diagnosis. Therefore, physicians must be aware of any factors that may increase an infant&#x02019;s risk of developing sepsis. Prematurity and very&#x000a0;low birth weights are also important risk factors to consider. Maternal factors that put neonates at risk of&#x000a0;EOS include GBS status, the presence of&#x000a0;chorioamnionitis, infant prematurity, or prolonged rupture of membranes&#x000a0;<xref ref-type="bibr" rid="article-25678.r3">[3]</xref>. Consider whether the patient has indwelling foreign bodies such as a central venous catheter or endotracheal tube for late-onset infection, depends on parenteral nutrition, or receives proton-pump inhibitor or histamine-2 blocking therapy.</p>
      </sec>
      <sec id="article-25678.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Neonates with bacteremia can be asymptomatic and have a normal physical examination. Thus, laboratory testing plays an important role in diagnosis. In a neonate with suspected sepsis, a blood culture should be immediately drawn. It is recommended to draw at least 1 ml of blood as low-level bacteremia may not be detected with smaller aliquotes&#x000a0;<xref ref-type="bibr" rid="article-25678.r10">[10]</xref>. Cultures should also be drawn from the catheter site if&#x000a0;1 is in place. Urine cultures are usually not recommended for evaluating EOS but should be considered for evaluating LOS&#x000a0;<xref ref-type="bibr" rid="article-25678.r11">[11]</xref>. Lumbar puncture with cerebrospinal fluid (CSF) analysis and culture should be evaluated in any infant with positive blood culture or if the neonate has a clinical presentation that suggests central nervous system involvement. Lumbar puncture should be repeated within 48 hours of therapy to confirm sterility of the CSF. New technology using polymerase chain reaction is currently being studied as a diagnostic tool to identify sepsis and the causative organism faster than blood cultures&#x000a0;<xref ref-type="bibr" rid="article-25678.r12">[12]</xref></p>
        <p>CSF analysis may reveal:</p>
        <list list-type="bullet">
          <list-item>
            <p>Elevated protein level</p>
          </list-item>
          <list-item>
            <p>Elevated WBC</p>
          </list-item>
          <list-item>
            <p>Positive cultures</p>
          </list-item>
          <list-item>
            <p>Decreased glucose concentration</p>
          </list-item>
          <list-item>
            <p>Positive polymerase chain reaction</p>
          </list-item>
        </list>
        <p>Complete blood count with differential and C-reactive protein is also an important lab test, often collected on a serial basis. These indices are poor at identifying neonatal sepsis but are better used for ruling it out&#x000a0;<xref ref-type="bibr" rid="article-25678.r10">[10]</xref>. Neutropenia has better specificity than neutrophilia as a marker of neonatal sepsis&#x000a0;<xref ref-type="bibr" rid="article-25678.r13">[13]</xref>. An elevated immature to total neutrophil ratio of more than 0.27 has a very high negative predictive accuracy (99%) but an inadequate positive predictive value (25%), as it may be elevated in up to 50% of uninfected infants&#x000a0;<xref ref-type="bibr" rid="article-25678.r14">[14]</xref><xref ref-type="bibr" rid="article-25678.r15">[15]</xref>. These counts may be falsely elevated, especially after birth. It is better to perform&#x000a0;complete blood count 6 to 12 hours to avoid the normal physiological&#x000a0;complete blood count parameters' changes seen immediately after delivery<xref ref-type="bibr" rid="article-25678.r16">[16]</xref>.&#x000a0;</p>
        <p>C-reactive protein&#x000a0;levels start rising within 6 to 8 hours during an infectious episode in neonates and peak at about 24 hours&#x000a0;<xref ref-type="bibr" rid="article-25678.r17">[17]</xref>. Persistently normal&#x000a0;C-reactive protein levels provide strong evidence against bacterial sepsis. This good correlation can support the clinical judgment of stopping antibiotics in an otherwise well-appearing neonate. Other inflammatory markers, including procalcitonin, haptoglobin, and cytokines, can also be obtained to support the diagnosis or evaluate treatment efficacy. Radiography of the chest may be performed to look for any pulmonary findings in a neonate with respiratory symptoms or signs.&#x000a0;</p>
      </sec>
      <sec id="article-25678.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Empiric antibiotic treatment should be started when sepsis is clinically suspected, even without confirmatory lab data. In general, antimicrobial resistance patterns of common bacteria in the neonatal intensive care unit should guide antibiotics' initial choice. Typical treatment regimens include intravenous (IV) ampicillin and aminoglycosides to cover the most common pathogens in EOS (GBS,&#x000a0;<italic toggle="yes">E. coli</italic>, and&#x000a0;<italic toggle="yes">L. monocytogenes)</italic>&#x000a0;<xref ref-type="bibr" rid="article-25678.r10">[10]</xref>. With LOS, nosocomial coverage should be provided for hospital-acquired pathogens such as coagulase-negative&#x000a0;<italic toggle="yes">Staphylococcus</italic>,&#x000a0;<italic toggle="yes">S. aureus</italic>, and&#x000a0;<italic toggle="yes">Pseudomonas</italic>&#x000a0;species. It is recommended that these patients be started on a combination of vancomycin and an aminoglycoside&#x000a0;<xref ref-type="bibr" rid="article-25678.r18">[18]</xref>. Aminoglycosides have poor CNS penetration; for that reason, a third-generation cephalosporin should be considered if CNS infection is suspected&#x000a0;<xref ref-type="bibr" rid="article-25678.r19">[19]</xref>. However, ceftriaxone should be avoided, as it can lead to hyperbilirubinemia and the serious precipitation of calcium-ceftriaxone crystals. Increasing antibiotic resistance is a concern for neonatal sepsis. Antibiotic stewardship teams play an essential role in preventing the unjustified prolonged use of antibiotics&#x000a0;<xref ref-type="bibr" rid="article-25678.r20">[20]</xref>.&#x000a0;</p>
      </sec>
      <sec id="article-25678.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Given the nonspecific signs of neonatal sepsis, several differentials must be considered, including but not limited to:</p>
        <list list-type="bullet">
          <list-item>
            <p>Infection due to other agents (virus, fungal or parasite)</p>
          </list-item>
          <list-item>
            <p>Congenital heart disease</p>
          </list-item>
          <list-item>
            <p>Neonatal encephalopathy</p>
          </list-item>
          <list-item>
            <p>Metabolic disease</p>
          </list-item>
          <list-item>
            <p>Prematurity and associated complications (respiratory distress syndrome, intraventricular hemorrhage, apnea of prematurity, and others)</p>
          </list-item>
          <list-item>
            <p>Hypo or hyperthyroidism</p>
          </list-item>
          <list-item>
            <p>Transient tachypnea of the newborn</p>
          </list-item>
          <list-item>
            <p>Meconium aspiration</p>
          </list-item>
          <list-item>
            <p>Hypoglycemia</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25678.s10" sec-type="Treatment Planning ">
        <title>Treatment Planning </title>
        <p>The treatment regimen for neonatal sepsis varies based on various risk factors and conditions. The typical antibiotics used are discussed above. The duration of therapy can vary based on the isolated organisms, the type of infection, and the presence of any neonatal complications. Neonates with positive blood cultures typically respond to treatment within 24 to 48 hours, and repeat cultures and studies are usually negative by 72 hours&#x000a0;<xref ref-type="bibr" rid="article-25678.r3">[3]</xref>. Persistent positive blood cultures should alert the clinicians to a seeding focus that should be managed (central venous access, cardiac vegetations, abscesses, or osteomyelitis). Many providers would continue intervenous therapy for 7 to 14 days based on the organism or longer if meningitis was suspected&#x000a0;<xref ref-type="bibr" rid="article-25678.r18">[18]</xref>. Increasing the duration of antibiotics may be necessary for some situations. Increasing the incidence of antibiotic resistance necrotizing enterocolitis or death are&#x000a0;2 crucial principles that should motivate clinicians to tailor antimicrobial therapy if clinically indicated<xref ref-type="bibr" rid="article-25678.r21">[21]</xref>.</p>
        <p>The treatment for suspect EOS with negative cultures is also variable. Cultures can be negative for various reasons, including maternal antibiotic use, initiation of antibiotics before obtaining cultures, or false-negative tests. Determining adequate antibiotic therapy without any positive cultures can make determining the duration of therapy difficult. Most neonates with highly suspected clinical sepsis with negative culture receive 7-10 days of antimicrobial therapy&#x000a0;<xref ref-type="bibr" rid="article-25678.r3">[3]</xref>.&#x000a0;</p>
      </sec>
      <sec id="article-25678.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Mortality rates are inversely proportional to gestational age, such that preterm or younger neonates have higher mortality rates than term neonates&#x000a0;<xref ref-type="bibr" rid="article-25678.r22">[22]</xref>.&#x000a0;<italic toggle="yes">E. coli</italic>&#x000a0;has also been found to be associated with a higher mortality rate when compared with GBS. As noted above, the introduction of GBS intrapartum antibiotic prophylaxis has decreased mortality rates caused by GBS. The treatment of clinically suspected neonates with negative cultures has also significantly decreased mortality rates. Preterm infants with sepsis may develop impaired neurodevelopment. Also, others may have vision impairment. Those infants pretreated with aminoglycosides may also develop ototoxicity and nephrotoxicity.</p>
      </sec>
      <sec id="article-25678.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Neonatal sepsis remains a significant contributor to morbidity and mortality in neonates. Prematurity and delayed treatment are commonly associated with adverse outcomes. VLBW infants have been found to have a higher risk of chronic lung disease, and extremely low birth weight infants are at a greater risk of neurodevelopmental risks, such as hearing and visual deficits, cerebral palsy, and impaired psychomotor and mental development&#x000a0;<xref ref-type="bibr" rid="article-25678.r23">[23]</xref>. On the other hand, the unnecessary overuse of antibiotics can increase the chances of severe candidiasis and multi-drug resistant organisms.</p>
      </sec>
      <sec id="article-25678.s13" sec-type="Consultations">
        <title>Consultations</title>
        <p>Pediatricians or neonatologists can adequately manage neonatal sepsis. However, the following subspecialties and ancillary services can provide essential support in complicated cases:</p>
        <list list-type="bullet">
          <list-item>
            <p>Pediatric surgery: to manage associated surgical complications (gastrointestinal perforation, abscess, necrotizing fasciitis, omphalitis, and others)</p>
          </list-item>
          <list-item>
            <p>Pediatric infectious disease specialist if the infant is not responding to antibiotics or if there is concern regarding adequate antimicrobial coverage</p>
          </list-item>
          <list-item>
            <p>Pediatric pharmacists can provide meaningful input and recommendations about monitoring trough levels to avoid toxic antibiotic levels</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25678.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Educating the neonate's family about the disease process and keeping them updated throughout the treatment process is an integral part of management. Neonatal sepsis is often an unexpected and scary situation for parents and caregivers. Doctors should be mindful of this and ensure that parents are informed of the tests that must be performed, the importance of each test, and the results. Any antibiotic or treatment plan changes must be communicated to the parents.Upon hospital discharge, caregivers of all infants, including healthy newborns, should be educated to watch for signs of illness or sepsis. These may include fever, jaundice, increased lethargy, decreased feeding habits, difficulty or increased breathing, and cyanosis of the fingertips and toes. Caregivers should be informed to call their doctors if their neonate experiences any of these symptoms, as they could indicate LOS.</p>
      </sec>
      <sec id="article-25678.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Neonatal sepsis is a significant cause of morbidity and mortality in neonates. Attempts to prevent sepsis's development or progression have driven many quality improvement projects in newborn nurseries and NICUs.Managing such infants is complex and requires a multidisciplinary care approach, including clinicians, pharmacies, lactation consultants, and social workers supported by medical decisions made during family-based care rounds. Obstetric physicians are important in ensuring that GBS screening and all other prenatal screening for infections are performed and adequately treated before and during delivery. Nursery nurses are also important in preventing and managing neonatal sepsis as they can pick up and detect early signs of sepsis. In-hospital pediatricians are essential in managing the evolving treatment of neonatal sepsis and making adjustments as necessary. They are also important in contacting the proper consultants, such as pediatric surgeons and pharmacists. Despite optimal treatment, neonatal sepsis continues to have high mortality rates and poor outcomes. While the mortality rates have started to decline, the recovery for most infants is prolonged, and there is a risk for neurodevelopmental disabilities.</p>
      </sec>
      <sec id="article-25678.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25678&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25678">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/child-health/neonatal-sepsis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=25678">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/25678/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=25678">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-25678.s17">
        <title>References</title>
        <ref id="article-25678.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Seale</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Blencowe</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Manu</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Nair</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Bahl</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Qazi</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Zaidi</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Berkley</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Cousens</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Lawn</surname>
                <given-names>JE</given-names>
              </name>
              <collab>pSBI Investigator Group</collab>
            </person-group>
            <article-title>Estimates of possible severe bacterial infection in neonates in sub-Saharan Africa, south Asia, and Latin America for 2012: a systematic review and meta-analysis.</article-title>
            <source>Lancet Infect Dis</source>
            <year>2014</year>
            <month>Aug</month>
            <volume>14</volume>
            <issue>8</issue>
            <fpage>731</fpage>
            <page-range>731-741</page-range>
            <pub-id pub-id-type="pmid">24974250</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25678.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wynn</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Defining neonatal sepsis.</article-title>
            <source>Curr Opin Pediatr</source>
            <year>2016</year>
            <month>Apr</month>
            <volume>28</volume>
            <issue>2</issue>
            <fpage>135</fpage>
            <page-range>135-40</page-range>
            <pub-id pub-id-type="pmid">26766602</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25678.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Simonsen</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Anderson-Berry</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Delair</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Davies</surname>
                <given-names>HD</given-names>
              </name>
            </person-group>
            <article-title>Early-onset neonatal sepsis.</article-title>
            <source>Clin Microbiol Rev</source>
            <year>2014</year>
            <month>Jan</month>
            <volume>27</volume>
            <issue>1</issue>
            <fpage>21</fpage>
            <page-range>21-47</page-range>
            <pub-id pub-id-type="pmid">24396135</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25678.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bizzarro</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Raskind</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Baltimore</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Gallagher</surname>
                <given-names>PG</given-names>
              </name>
            </person-group>
            <article-title>Seventy-five years of neonatal sepsis at Yale: 1928-2003.</article-title>
            <source>Pediatrics</source>
            <year>2005</year>
            <month>Sep</month>
            <volume>116</volume>
            <issue>3</issue>
            <fpage>595</fpage>
            <page-range>595-602</page-range>
            <pub-id pub-id-type="pmid">16140698</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25678.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Van Dyke</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Phares</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Lynfield</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Arnold</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Craig</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Mohle-Boetani</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gershman</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Schaffner</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Petit</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zansky</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Morin</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Spina</surname>
                <given-names>NL</given-names>
              </name>
              <name>
                <surname>Wymore</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Harrison</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Shutt</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Bareta</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bulens</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Zell</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Schuchat</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Schrag</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of universal antenatal screening for group B streptococcus.</article-title>
            <source>N Engl J Med</source>
            <year>2009</year>
            <month>Jun</month>
            <day>18</day>
            <volume>360</volume>
            <issue>25</issue>
            <fpage>2626</fpage>
            <page-range>2626-36</page-range>
            <pub-id pub-id-type="pmid">19535801</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25678.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shane</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Stoll</surname>
                <given-names>BJ</given-names>
              </name>
            </person-group>
            <article-title>Recent developments and current issues in the epidemiology, diagnosis, and management of bacterial and fungal neonatal sepsis.</article-title>
            <source>Am J Perinatol</source>
            <year>2013</year>
            <month>Feb</month>
            <volume>30</volume>
            <issue>2</issue>
            <fpage>131</fpage>
            <page-range>131-41</page-range>
            <pub-id pub-id-type="pmid">23297182</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25678.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weston</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Pondo</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lewis</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Martell-Cleary</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Morin</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Jewell</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Daily</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Apostol</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Petit</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Farley</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lynfield</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Reingold</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hansen</surname>
                <given-names>NI</given-names>
              </name>
              <name>
                <surname>Stoll</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Shane</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Zell</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Schrag</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>The burden of invasive early-onset neonatal sepsis in the United States, 2005-2008.</article-title>
            <source>Pediatr Infect Dis J</source>
            <year>2011</year>
            <month>Nov</month>
            <volume>30</volume>
            <issue>11</issue>
            <fpage>937</fpage>
            <page-range>937-41</page-range>
            <pub-id pub-id-type="pmid">21654548</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25678.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stoll</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Hansen</surname>
                <given-names>NI</given-names>
              </name>
              <name>
                <surname>S&#x000e1;nchez</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Faix</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Poindexter</surname>
                <given-names>BB</given-names>
              </name>
              <name>
                <surname>Van Meurs</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Bizzarro</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Goldberg</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Frantz</surname>
                <given-names>ID</given-names>
              </name>
              <name>
                <surname>Hale</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Shankaran</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kennedy</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Carlo</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Watterberg</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Bell</surname>
                <given-names>EF</given-names>
              </name>
              <name>
                <surname>Walsh</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Schibler</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Laptook</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Shane</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Schrag</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Higgins</surname>
                <given-names>RD</given-names>
              </name>
              <collab>Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network</collab>
            </person-group>
            <article-title>Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues.</article-title>
            <source>Pediatrics</source>
            <year>2011</year>
            <month>May</month>
            <volume>127</volume>
            <issue>5</issue>
            <fpage>817</fpage>
            <page-range>817-26</page-range>
            <pub-id pub-id-type="pmid">21518717</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25678.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Raymond</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Stortz</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Mira</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Larson</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Wynn</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Moldawer</surname>
                <given-names>LL</given-names>
              </name>
            </person-group>
            <article-title>Immunological Defects in Neonatal Sepsis and Potential Therapeutic Approaches.</article-title>
            <source>Front Pediatr</source>
            <year>2017</year>
            <volume>5</volume>
            <fpage>14</fpage>
            <pub-id pub-id-type="pmid">28224121</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25678.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Polin</surname>
                <given-names>RA</given-names>
              </name>
              <collab>Committee on Fetus and Newborn</collab>
            </person-group>
            <article-title>Management of neonates with suspected or proven early-onset bacterial sepsis.</article-title>
            <source>Pediatrics</source>
            <year>2012</year>
            <month>May</month>
            <volume>129</volume>
            <issue>5</issue>
            <fpage>1006</fpage>
            <page-range>1006-15</page-range>
            <pub-id pub-id-type="pmid">22547779</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25678.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Visser</surname>
                <given-names>VE</given-names>
              </name>
              <name>
                <surname>Hall</surname>
                <given-names>RT</given-names>
              </name>
            </person-group>
            <article-title>Urine culture in the evaluation of suspected neonatal sepsis.</article-title>
            <source>J Pediatr</source>
            <year>1979</year>
            <month>Apr</month>
            <volume>94</volume>
            <issue>4</issue>
            <fpage>635</fpage>
            <page-range>635-8</page-range>
            <pub-id pub-id-type="pmid">430312</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25678.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mazzucchelli</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Garofoli</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Angelini</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tinelli</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tzialla</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Decembrino</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Rapid detection of bacteria in bloodstream infections using a molecular method: a pilot study with a neonatal diagnostic kit.</article-title>
            <source>Mol Biol Rep</source>
            <year>2020</year>
            <month>Jan</month>
            <volume>47</volume>
            <issue>1</issue>
            <fpage>363</fpage>
            <page-range>363-368</page-range>
            <pub-id pub-id-type="pmid">31642041</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25678.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Manroe</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Weinberg</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Rosenfeld</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Browne</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>The neonatal blood count in health and disease. I. Reference values for neutrophilic cells.</article-title>
            <source>J Pediatr</source>
            <year>1979</year>
            <month>Jul</month>
            <volume>95</volume>
            <issue>1</issue>
            <fpage>89</fpage>
            <page-range>89-98</page-range>
            <pub-id pub-id-type="pmid">480023</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25678.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lloyd</surname>
                <given-names>BW</given-names>
              </name>
              <name>
                <surname>Oto</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Normal values for mature and immature neutrophils in very preterm babies.</article-title>
            <source>Arch Dis Child</source>
            <year>1982</year>
            <month>Mar</month>
            <volume>57</volume>
            <issue>3</issue>
            <fpage>233</fpage>
            <page-range>233-5</page-range>
            <pub-id pub-id-type="pmid">7073305</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25678.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gerdes</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Polin</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Sepsis screen in neonates with evaluation of plasma fibronectin.</article-title>
            <source>Pediatr Infect Dis J</source>
            <year>1987</year>
            <month>May</month>
            <volume>6</volume>
            <issue>5</issue>
            <fpage>443</fpage>
            <page-range>443-6</page-range>
            <pub-id pub-id-type="pmid">3601490</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25678.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rozycki</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Stahl</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Baumgart</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Impaired sensitivity of a single early leukocyte count in screening for neonatal sepsis.</article-title>
            <source>Pediatr Infect Dis J</source>
            <year>1987</year>
            <month>May</month>
            <volume>6</volume>
            <issue>5</issue>
            <fpage>440</fpage>
            <page-range>440-2</page-range>
            <pub-id pub-id-type="pmid">3601489</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25678.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gabay</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kushner</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Acute-phase proteins and other systemic responses to inflammation.</article-title>
            <source>N Engl J Med</source>
            <year>1999</year>
            <month>Feb</month>
            <day>11</day>
            <volume>340</volume>
            <issue>6</issue>
            <fpage>448</fpage>
            <page-range>448-54</page-range>
            <pub-id pub-id-type="pmid">9971870</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25678.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cortese</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Scicchitano</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gesualdo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Filaninno</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>De Giorgi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Schettini</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Laforgia</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ciccone</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>Early and Late Infections in Newborns: Where Do We Stand? A Review.</article-title>
            <source>Pediatr Neonatol</source>
            <year>2016</year>
            <month>Aug</month>
            <volume>57</volume>
            <issue>4</issue>
            <fpage>265</fpage>
            <page-range>265-73</page-range>
            <pub-id pub-id-type="pmid">26750406</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25678.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sullins</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Abdel-Rahman</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Pharmacokinetics of antibacterial agents in the CSF of children and adolescents.</article-title>
            <source>Paediatr Drugs</source>
            <year>2013</year>
            <month>Apr</month>
            <volume>15</volume>
            <issue>2</issue>
            <fpage>93</fpage>
            <page-range>93-117</page-range>
            <pub-id pub-id-type="pmid">23529866</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25678.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shane</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>S&#x000e1;nchez</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Stoll</surname>
                <given-names>BJ</given-names>
              </name>
            </person-group>
            <article-title>Neonatal sepsis.</article-title>
            <source>Lancet</source>
            <year>2017</year>
            <month>Oct</month>
            <day>14</day>
            <volume>390</volume>
            <issue>10104</issue>
            <fpage>1770</fpage>
            <page-range>1770-1780</page-range>
            <pub-id pub-id-type="pmid">28434651</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25678.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dong</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Speer</surname>
                <given-names>CP</given-names>
              </name>
            </person-group>
            <article-title>Late-onset neonatal sepsis: recent developments.</article-title>
            <source>Arch Dis Child Fetal Neonatal Ed</source>
            <year>2015</year>
            <month>May</month>
            <volume>100</volume>
            <issue>3</issue>
            <fpage>F257</fpage>
            <page-range>F257-63</page-range>
            <pub-id pub-id-type="pmid">25425653</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25678.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stoll</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Hansen</surname>
                <given-names>NI</given-names>
              </name>
              <name>
                <surname>Bell</surname>
                <given-names>EF</given-names>
              </name>
              <name>
                <surname>Shankaran</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Laptook</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Walsh</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Hale</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Newman</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Schibler</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Carlo</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Kennedy</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Poindexter</surname>
                <given-names>BB</given-names>
              </name>
              <name>
                <surname>Finer</surname>
                <given-names>NN</given-names>
              </name>
              <name>
                <surname>Ehrenkranz</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Duara</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>S&#x000e1;nchez</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>O'Shea</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Goldberg</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Van Meurs</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Faix</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Phelps</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Frantz</surname>
                <given-names>ID</given-names>
              </name>
              <name>
                <surname>Watterberg</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Saha</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Higgins</surname>
                <given-names>RD</given-names>
              </name>
              <collab>Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network</collab>
            </person-group>
            <article-title>Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network.</article-title>
            <source>Pediatrics</source>
            <year>2010</year>
            <month>Sep</month>
            <volume>126</volume>
            <issue>3</issue>
            <fpage>443</fpage>
            <page-range>443-56</page-range>
            <pub-id pub-id-type="pmid">20732945</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25678.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wynn</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>HR</given-names>
              </name>
            </person-group>
            <article-title>Pathophysiology and treatment of septic shock in neonates.</article-title>
            <source>Clin Perinatol</source>
            <year>2010</year>
            <month>Jun</month>
            <volume>37</volume>
            <issue>2</issue>
            <fpage>439</fpage>
            <page-range>439-79</page-range>
            <pub-id pub-id-type="pmid">20569817</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
